fda glp-1 compounding enforcement news and Novo Nordisk Warn of Telehealth Take Down – What's Next? GLP-1 Drugs: Brand Companies Push

It enhances glucose-dependent insulin secretion, suppresses glucagon, and slows gastric emptying key mechanisms for glucose control

2 GLP-1R monotherapy (e.g., semaglutide) is highly effective, but dual GLP-1R/GIPR agonists (e.g.,

A series of state and federal lawsuits challenging coverage exclusions for obesity drugs and procedures are testing the bounds of what qualifies as a disability under discrimination laws as more workers seek to access the expensive treatments.

The ICD-11 is a classification and coding system used by physicians and other healthcare providers, to indicate an exact diagnosis including its type, variant and even the severity of a person's condition.

Unlike diabetic ketoacidosis, the diagnosis of euglycemic diabetic ketoacidosisis often overlooked because of the absence of hyperglycemia.

Background Guidelines recommend combination therapy with glucagonlike peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) for cardiorenal risk reduction in people with type 2 diabetes (T2D)